OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>
November 1, 2023 The Evidence Base Read the full article >> In a recent presentation at the DIA Real-Word Evidence (RWE) Conference (October 16–17, 2023, Baltimore, MD, USA), Sonja Wustrack, Managing Director of Integrated Evidence Generation at OM1 (MA, USA), discussed strategies for optimizing evidence generation in clinical research. She described the OM1 approach to[…]
HIT Consultant October 3, 2023 Read the full article >> What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient[…]
Dermatology Times October 3, 2023 Read the full article >> OM1, a real-world data and AI technology company, recently announced the continued expansion of its Dermatology Network to now include hidradenitis suppurativa (HS), adding approximately 26,000 new patient records to its database. The addition of the HS database will help find innovative solutions and improve health outcomes[…]
Dermatology Times October 3, 2023 Read the full article >> Artificial intelligence (AI) has been a buzzword in health care for some time, but do clinicians, especially in dermatology, view it as friend or foe? Applications and use of AI in dermatology are comparatively new and have focused primarily on the relatively narrow application of[…]
